Brand Name

Biltricide

Generic Name
Praziquantel
View Brand Information
FDA approval date: April 21, 2011
Classification: Anthelmintic
Form: Tablet

What is Biltricide (Praziquantel)?

Biltricide is indicated in patients aged 1 year and older for the treatment of the following infections: Schistosomiasis due to all species of schistosoma , and, Clonorchiasis and Opisthorchiasis due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini Biltricide is an anthelmintic indicated in patients aged one year and older for the treatment of the following infections:, Schistosomiasis due to all species of schistosoma , and, Clonorchiasis and Opisthorchiasis due to the liver flukes, Clonorchis sinensis and Opisthorchis viverrini.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

Natural History of Treated Neurocysticercosis and Long-Term Outcomes

Summary: Neurocysticercosis is a brain disease due to the larval stage of the pork tapeworm (Taenia solium). The most common symptoms patient experience from infection inside the substance of the brain (parenchymal disease) are seizures and headaches. When the infection is either inside the fluid pockets inside the brain (ventricular disease) or in the space around the brain (subarachnoid disease) patients...

A Community Mapping and Participatory Research Protocol for Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations Through Social and Occupational Networks in Nigeria: MISSION Nigeria

Summary: Neglected Tropical Diseases (NTDs) are among the most common groups of diseases affecting over one billion people globally and are disproportionately concentrated in remote, underserved, and marginalized communities. Efforts toward NTD elimination have largely relied on preventive chemotherapy (PC), large-scale distribution of free, safe, and effective medicines to at-risk populations. One major c...